BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38429159)

  • 1. Lessons from genetic studies in Alzheimer disease.
    Nicolas G
    Rev Neurol (Paris); 2024 May; 180(5):368-377. PubMed ID: 38429159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data.
    Campion D; Charbonnier C; Nicolas G
    Acta Neuropathol; 2019 Aug; 138(2):173-186. PubMed ID: 30911827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Common to Rare Variants: The Genetic Component of Alzheimer Disease.
    Nicolas G; Charbonnier C; Campion D
    Hum Hered; 2016; 81(3):129-141. PubMed ID: 28002825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in Alzheimer disease genetics.
    Nicolas G
    Curr Opin Neurol; 2024 Apr; 37(2):154-165. PubMed ID: 38235704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What contribution can genetics make to predict the risk of Alzheimer's disease?
    Schramm C; Wallon D; Nicolas G; Charbonnier C
    Rev Neurol (Paris); 2022 May; 178(5):414-421. PubMed ID: 35491248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.
    Louwersheimer E; Cohn-Hokke PE; Pijnenburg YA; Weiss MM; Sistermans EA; Rozemuller AJ; Hulsman M; van Swieten JC; van Duijn CM; Barkhof F; Koene T; Scheltens P; Van der Flier WM; Holstege H
    J Alzheimers Dis; 2017; 56(1):63-74. PubMed ID: 27911290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of Alzheimer's disease.
    Chouraki V; Seshadri S
    Adv Genet; 2014; 87():245-94. PubMed ID: 25311924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Search for risk genes in Alzheimer's disease].
    Karaca I; Wagner H; Ramirez A
    Nervenarzt; 2017 Jul; 88(7):744-750. PubMed ID: 28577227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability of Alzheimer's disease based on common and rare genetic variants.
    Escott-Price V; Schmidt KM
    Alzheimers Res Ther; 2021 Aug; 13(1):140. PubMed ID: 34404470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
    Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
    Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes.
    Schramm C; Charbonnier C; Zaréa A; Lacour M; Wallon D; ; Boland A; Deleuze JF; Olaso R; ; Alarcon F; Campion D; Nuel G; Nicolas G
    Genome Med; 2022 Jun; 14(1):69. PubMed ID: 35761418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic landscape of Alzheimer disease: clinical implications and perspectives.
    Van Cauwenberghe C; Van Broeckhoven C; Sleegers K
    Genet Med; 2016 May; 18(5):421-30. PubMed ID: 26312828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease.
    Holstege H; Hulsman M; Charbonnier C; Grenier-Boley B; Quenez O; Grozeva D; van Rooij JGJ; Sims R; Ahmad S; Amin N; Norsworthy PJ; Dols-Icardo O; Hummerich H; Kawalia A; Amouyel P; Beecham GW; Berr C; Bis JC; Boland A; Bossù P; Bouwman F; Bras J; Campion D; Cochran JN; Daniele A; Dartigues JF; Debette S; Deleuze JF; Denning N; DeStefano AL; Farrer LA; Fernández MV; Fox NC; Galimberti D; Genin E; Gille JJP; Le Guen Y; Guerreiro R; Haines JL; Holmes C; Ikram MA; Ikram MK; Jansen IE; Kraaij R; Lathrop M; Lemstra AW; Lleó A; Luckcuck L; Mannens MMAM; Marshall R; Martin ER; Masullo C; Mayeux R; Mecocci P; Meggy A; Mol MO; Morgan K; Myers RM; Nacmias B; Naj AC; Napolioni V; Pasquier F; Pastor P; Pericak-Vance MA; Raybould R; Redon R; Reinders MJT; Richard AC; Riedel-Heller SG; Rivadeneira F; Rousseau S; Ryan NS; Saad S; Sanchez-Juan P; Schellenberg GD; Scheltens P; Schott JM; Seripa D; Seshadri S; Sie D; Sistermans EA; Sorbi S; van Spaendonk R; Spalletta G; Tesi N; Tijms B; Uitterlinden AG; van der Lee SJ; Visser PJ; Wagner M; Wallon D; Wang LS; Zarea A; Clarimon J; van Swieten JC; Greicius MD; Yokoyama JS; Cruchaga C; Hardy J; Ramirez A; Mead S; van der Flier WM; van Duijn CM; Williams J; Nicolas G; Bellenguez C; Lambert JC
    Nat Genet; 2022 Dec; 54(12):1786-1794. PubMed ID: 36411364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.
    Le Guen Y; Belloy ME; Grenier-Boley B; de Rojas I; Castillo-Morales A; Jansen I; Nicolas A; Bellenguez C; Dalmasso C; Küçükali F; Eger SJ; Rasmussen KL; Thomassen JQ; Deleuze JF; He Z; Napolioni V; Amouyel P; Jessen F; Kehoe PG; van Duijn C; Tsolaki M; Sánchez-Juan P; Sleegers K; Ingelsson M; Rossi G; Hiltunen M; Sims R; van der Flier WM; Ramirez A; Andreassen OA; Frikke-Schmidt R; Williams J; Ruiz A; Lambert JC; Greicius MD; ; Arosio B; Benussi L; Boland A; Borroni B; Caffarra P; Daian D; Daniele A; Debette S; Dufouil C; Düzel E; Galimberti D; Giedraitis V; Grimmer T; Graff C; Grünblatt E; Hanon O; Hausner L; Heilmann-Heimbach S; Holstege H; Hort J; Jürgen D; Kuulasmaa T; van der Lugt A; Masullo C; Mecocci P; Mehrabian S; de Mendonça A; Moebus S; Nacmias B; Nicolas G; Olaso R; Papenberg G; Parnetti L; Pasquier F; Peters O; Pijnenburg YAL; Popp J; Rainero I; Ramakers I; Riedel-Heller S; Scarmeas N; Scheltens P; Scherbaum N; Schneider A; Seripa D; Soininen H; Solfrizzi V; Spalletta G; Squassina A; van Swieten J; Tegos TJ; Tremolizzo L; Verhey F; Vyhnalek M; Wiltfang J; Boada M; García-González P; Puerta R; Real LM; Álvarez V; Bullido MJ; Clarimon J; García-Alberca JM; Mir P; Moreno F; Pastor P; Piñol-Ripoll G; Molina-Porcel L; Pérez-Tur J; Rodríguez-Rodríguez E; Royo JL; Sánchez-Valle R; Dichgans M; Rujescu D
    JAMA Neurol; 2022 Jul; 79(7):652-663. PubMed ID: 35639372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome sequencing for early-onset or atypical dementia: high diagnostic yield and frequent observation of multiple contributory alleles.
    Cochran JN; McKinley EC; Cochran M; Amaral MD; Moyers BA; Lasseigne BN; Gray DE; Lawlor JMJ; Prokop JW; Geier EG; Holt JM; Thompson ML; Newberry JS; Yokoyama JS; Worthey EA; Geldmacher DS; Love MN; Cooper GM; Myers RM; Roberson ED
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31836585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenge accepted: uncovering the role of rare genetic variants in Alzheimer's disease.
    Khani M; Gibbons E; Bras J; Guerreiro R
    Mol Neurodegener; 2022 Jan; 17(1):3. PubMed ID: 35000612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
    Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Alzheimer's disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers.
    Park JH; Park I; Youm EM; Lee S; Park JH; Lee J; Lee DY; Byun MS; Lee JH; Yi D; Chung SJ; Park KW; Choi N; Kim SY; Yoon W; An H; Kim KW; Choi SH; Jeong JH; Kim EJ; Kang H; Lee J; Kim Y; Lee EA; Seo SW; Na DL; Kim JW
    Transl Psychiatry; 2021 May; 11(1):296. PubMed ID: 34011927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.